Member Info for JustHereForHemo

No, what I said was I dont know and you dont know so stop guessing. So yet again you are making false statements. For someone who loves to jump all over other people and attack you really love to make false statements of fact, the exact thing you accuse others off? Odd...

Sad twat, no they are not burning though 400k a month. Yet. But in a few months they will accelerate the HG-CT-1 trial and would like to resume work on CBR and CDX, how much exactly do you think all that costs? They SHOULD be spending north of 500k per month and by the end of the year/next year they should be. Go and find me another pharma with multiple patients in clinical trials with CAR-T having spent no more than £20m IN THEIR ENTIRE EXISTANCE. I will wait.

Got it, your guessing, stu refuses to say what he thinks Hemogenyx is worth and I have just been told to stop biting. So I will nite all!

Don't be an idiot, p3 was likely recruited weeks ago, you know fine rightly that the company aimed to infuse every 28 days. Issues between 1 and 2 hopefully were a 1 off. P3 easily could be in the lypodepletion stage or possibly even infused, today is day 28? So if you know for a fact then fine, state your sources, otherwise your guessing.

There are 2 or 3, I don't know for sure and neither do you so I won't be making assumptions thank you very much.

4-5 months ago Hemogenyx were not clinical, we were significantly undervalued and frustrated at the SP and mCap, but we were reliant on shareholders and traders to recognise the value and buy to support the SP. We lacked the support of the market needed to buy available stock and cover any dilution and as a result SP is where it is.

Today Hemogenyx are clinical, there are 2-3 patients in trial and so far looking good, and with clinical results Hemo and HG-CT-1 is looking more and more attractive to big pharma. 2 weeks ago we did not have a patient at 3 months, 2 months ago we did not have any efficacy results from bone marrow, its just not the same now.

We are not going to get the funding we need from shareholders swallowing discount placings its categorically not going to happen, they need millions and even if the vote for 100% is passed and they raised the full whack next week that would not pay for trials for a year.

Been alot of talk about Senti Biosciences and their FLT3 candidate, as per Haywain it validates our choice of target, its the same, if it works for Senti it works for us. HOWEVER CAR-T is longer lasting and more effective over time vs the short lived CAR-NK, for senti one patient experienced complete remission and was deemed cancer free which is fantastic but others needed BMT and further treatment. HG-CT-1 hopefully will be a one dose treatment, either way they are distinct enough that the FDA will likely approve both in time.

So Senti Validates us and they are months ahead in trials, lets say they get approved and bought out by a big pharma..... Does that mean that all the other big pharma go and beg for a licence also or do they just let the buyer hold a market monopoly on AML? There is ALWAYS competition, its a race for IP, if someone buys Senti their direct competitor will want something to compete, right now there is not a lot of options.

I really do wonder how so many people cannot see the writing on the wall, at 7million the mCap of Hemogenyx is a joke, a literal joke, HG-CT-1 is a slightly superior analogue to Senti which is 1000% more expensive than Hemogenyx and every patient they treat validates HG-CT-1 and its choice of anti FLT3 as a target and YES, big pharma are starting to twig on.

Totally agree HFH, The AGM is an annual formality and nothing more, quite often completed in minutes, I doubt if Vlad will even attend this year, last year there was an email that he would be over. As for an RNS, without question an RNS on efficacy will be needed soon, there is a difference between Hemogenyx and BMS, one is multi billion the other is 7million mCap. And while idiots like Stu might try and push the narrative that we wont know for potentially years.... Seriously???? Without HG-CT-1 these patients would not survive, likely weeks in some cases but almost certainly months, this is science, AML is measurable in both blood and bone marrow. Hemogenyx know if HG-CT-1 works, MD Anderson know if it works and I can guarantee you the patients receiving the treatment know, because either it works and they are able to go home and spend time with their families or they are in and out of hospital getting platelets and chemo.

I wont start a long engagement, in fact if Stu answers this one question I will not post on LSE again today, but he wont.

@Stu - You are very keen to put people off investing here so you clearly think its a bad investment and over valued at £7million. So WHAT DO YOU value Hemogenyx at? What is YOUR target mCap?

100% KP!

I expect the patient treatment cadence to be closer to the 1month cycle than it was between p1 and p2 which means VERY soon for P3, I am also very reassured by the lack of bad news, as we know Vlad is quick to release bad news, slow to release good news. What updates will we receive? Thats anybody's guess but I am expecting an update on 28day P2 + treatment of P3 again which will be another huge green tick :-)

Its a really hard equation to square jxf. If EVERYONE just did not reply then any new POTENTIAL investor visiting this board will see his massive post with new lines between every sentence. And from start to finish every post of his is crafted to infuse doubt and fear and discourage investment, a new visitor sees his post and just moves on, alot of people dont read more than the top 1 or 2 posts on a board when they are scanning the market. OR an existing shareholder who literally looks at their PF once a month, visits the board to see why the SP is so pants and sees posts like his and thinks "Wow, sounds like I should sell!" If people DONT post after him then will new people really read past him? If people dont counter him do you think people reading are going to fact check? I dont. Then there is fact that when people like Haywain reply...... Jesus its like being taken to school and realising just how much you did not know. Haywain, And others! Have replied ot Stu and its from those replies that I have learned so much more, like the durability between CAR-NK and CAR-T, the fact that NK is more a stepping stone than a final cure of CAR-T the cross validation without being a threat to Hemo? Timelines to CMR from initial BM sampling and why HG-CT-1 is better than other CAR-Ts for RR AML, this all came from replies to Stu which make him look very stupid and give the rest of us the confidence that we are stupid when it comes to blood cancer but atleast we know there is one matter expert and he says Hemo is a game changer. So yes I 100% agree with the sentiment, and people like me who cannot add much scientifically should not give him oxygen, but personally I welcome when Haywain takes stu to the woodshed and whoops his backside.

So stu, since your on the overtime, answer my question. Your stating now the target FLT3 appears to work and is validated but Hemo are not the first to target it OR the first to use CAR-T to target AML... OK....

As per Haywains excellent post there is a difference between CAR-T and CAR-NK and a market for both.

So answer my question WHAT IS HEMOGENYX WORTH?

You clearly don't want people buying so what's your target mCap? WHEN is hemo cheap enough for you? 7mil for HG-CT-1 AND CBR AND CDX is too much? So what do you value HG-CT-1 worth???? Or are you just simply hoping to drown out posts from Haywain and spread empty FUD and BS?

Stu wants to convince everyone that Hemogenyx pharma is not worth £7m. At this point he is a joke and engaging with him does nothing but give him what he wants. To bury the post from Haywain. Haywain PLEASE REPOST.

Stu trying to argue that Hemogenyx, let alone HG-CT-1 is not worth £7m. He is a joke with a clear agenda. Also does not seem to realise its a bank holiday, not getting paid today so surprised to see him on.

Most people on here bought shares through a broker, those shares are owned by the broker and held in a trustee account along with every other customer of that broker. The broker votes on your behalf and if you want to vote in person then your broker can provide a form. The one on the website is just a sample it says cancelled the same way toy money might say fake.

Does it really matter what he posts? HG-CT-1 is in clinical trials and we are about to get month 3 results. It's worth considerably more than 7m. Everything else is noise.

Stu thinks Hemogenyx with HG-CT-1 in clinical trials is not worth 7m.

End of discussion. The rest is just noise. He is a troll here with one agenda.

Stu thinks Hemogenyx with HG-CT-1 in clinical trials is not worth 7m.

End of discussion. He is a troll here with one agenda.

Love how you call out me but never a word against the likes of LST, perhaps share a bit of your preaching to both sides of the aisle and I would!

HT, your just on a personal crusade because your sad and bitter, I'm here because I want to be and know what Hemogenyx is worth despite the current mcap. Your here because you invested in Silver Falcon and have seen your investment decimated and I'm guessing spend all your money on alcohol? So never averaged down and plan to spend the rest of your days moaning. Let's face it if I'm in over my head your buried 6 feet deep. You are a sad lonely pathetic old man and you WANT Hemogenyx to fail because even though you are a shareholder you would hate any of the rest of us to make more profit than you, and yes don't forget the warrants, I know how much they peeve you off, I have lots ty 😊

So, just so we are clear, you using a beautiful Friday evening to use the fact that an 85k sell may or may not have been a placee who may have sold 1/3 of his shares to personally attack me who never said anything about the class of placee? You realise I don't care? I actually think the placing was one of the best, no discount means despite him possibly selling 85k we are still at 180. You have literally no clue do you? You live to look for ways to attack people on lse. Genuine question, are you pumpkin?

Anyway you have sucked enough of my time, this is getting sad, I have no interest in sharing anything with you so if I keep replying it's just going to be calling you an idiot which is a waste of both of our times. So you have a wonderful weekend 😆

Please go find where I said it was a long term investor, what mattered to me was NO DISCOUNT, Simples!

Ps you really do have a sad life lol, like this is pathetic, do you still hold or are you just lurking like a sad ex??